Filtered By:
Source: ScienceDaily Headlines
Drug: Tamoxifen
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
No increased risk of fatal cardiovascular events for breast cancer patients on newer hormone therapy
The use of aromatase inhibitors, hormone-therapy drugs used to treat patients with breast cancer, was not associated with an increased risk of fatal cardiovascular events, including heart attacks or stroke, compared with tamoxifen, another commonly prescribed anti-cancer drug that works on hormones and which has been associated with a serious risk of stroke, report investigators.
Source: ScienceDaily Headlines - April 21, 2016 Category: Science Source Type: news
